12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks showed significant movement in Monday's intraday session, with notable gainers including CareCloud, Novavax, and Macrogenics, and losers like TransCode Therapeutics and Applied DNA Sciences. Earnings reports influenced several stock movements.
May 13, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences fell 22.03% to $2.69 following its Q2 earnings, with a market cap of $2.3 million, indicating a negative market reaction to its financial results.
The decline in Applied DNA Sciences' stock price post-Q2 earnings suggests a negative reception of its financial results by the market, potentially impacting investor sentiment.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
TransCode Therapeutics saw a 40.1% decline to $0.84, with a market cap of $5.1 million, indicating potential concerns or negative reactions to company developments.
The sharp decline in TransCode Therapeutics' stock price may reflect investor concerns or negative reactions to recent company developments or market conditions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
CareCloud's stock surged 80.5% to $2.27, with a market cap of $36.6 million, indicating strong investor confidence.
The significant surge in CareCloud's stock price likely reflects positive investor sentiment, possibly due to recent company developments or broader market trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Novavax rose 42.17% to $12.62 following its Q1 earnings report, with a market cap of $1.7 billion, suggesting positive reception of its financial performance.
The rise in Novavax's stock price post-earnings suggests the market positively received its Q1 financial performance, indicating potential growth.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90